Condition: Rhinitis, Allergic · Rhinoconjunctivitis · Asthma, Allergic · Sponsor: Inmunotek S.L.
A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma Sensitized to cupressaceae and grasses.
This description comes directly from the study's public registry record.
Miguel Casanovas, MD PhD · +34 912908942 · mcasanovas@inmunotek.com
Raquel Caballero · +34 607600638 · rcaballero@inmunotek.com
Always discuss trial participation with your own doctor first.
| Hospital Recoletas Felipe Ii | Valladolid, Castille and León, Spain | Recruiting |
| Cedt de Tarancón | Tarancón, Cuenca, Spain | Recruiting |
| Hospital Universitario Principe de Asturias | Alcalá de Henares, Madrid, Spain | Completed |
| Hospital U. Fundación Alcorcón | Alcorcón, Madrid, Spain | Recruiting |
| Hospital Cruz Roja Madrid | Madrid, Madrid, Spain | Recruiting |
| Clínica Privada Dres Ojeda | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario Puerta de Hierro | Majadahonda, Madrid, Spain | Not Yet Recruiting |
| Clínica Privada Murcia | Murcia, Murcia, Spain | Not Yet Recruiting |
| Hospital Nuestra Señora de Sonsoles | Ávila, Spain | Not Yet Recruiting |
| Fundación Hospital Sant Pere Claver | Barcelona, Spain | Withdrawn |
| Clínica privada Burgos | Burgos, Spain | Withdrawn |
| Hospital Universitario de Burgos | Burgos, Spain | Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04898283